公开(公告)号：WO2009005675A1

公开(公告)日：2009-01-08

申请号：PCT/US2008/007926

申请日：2008-06-26

Applicant: ABBOTT LABORATORIES ,  CALDERWOOD, David J. ,  BONAFOUX, Dominique F. ,  BURCHAT, Andrew ,  DING, Ping ,  FRANK, Kristine E. ,  HOEMANN, Michael Z. ,  MULLEN, Kelly D. ,  DAVIS, Heather M.

Inventor： CALDERWOOD, David J. ,  BONAFOUX, Dominique F. ,  BURCHAT, Andrew ,  DING, Ping ,  FRANK, Kristine E. ,  HOEMANN, Michael Z. ,  MULLEN, Kelly D. ,  DAVIS, Heather M.

IPC: A61K31/535 ,  A61K31/50 ,  A61K31/519

CPC classification number: C07D487/04 ,  C07D519/00

Abstract: The present invention is directed to novel compounds of formula (I), wherein the variables are defined as herein. The compounds of formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.

Abstract translation: 本发明涉及新的式（I）化合物，其中变量如本文所定义。 式（I）化合物可用作激酶抑制剂，因此可用于治疗某些病症和疾病，特别是炎性病症和疾病以及增殖性疾病和病症，例如癌症。

公开(公告)号：EP2068869A2

公开(公告)日：2009-06-17

申请号：EP07870771.8

申请日：2007-10-05

Applicant: ABBOTT LABORATORIES

Inventor： BORHANI, David W. ,  CALDERWOOD, David J. ,  FRANK, Kristine E. ,  DAVIS, Heather M. ,  JOSEPHSOHN, Nathan S. ,  SKINNER, Barbara S.

IPC: A61K31/41 ,  C07D257/04

CPC classification number: C07D498/04 ,  C07D513/04 ,  C07D519/00

Abstract: The present invention is directed to novel compounds of formula (I) wherein the variables are as defined herein. The compounds of formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.

公开(公告)号：EP2170337A1

公开(公告)日：2010-04-07

申请号：EP08779770.0

申请日：2008-06-26

Applicant: Abbott Laboratories

Inventor： CALDERWOOD, David J. ,  BONAFOUX, Dominique F. ,  BURCHAT, Andrew ,  DING, Ping ,  FRANK, Kristine E. ,  HOEMANN, Michael Z. ,  MULLEN, Kelly D. ,  DAVIS, Heather M.

IPC: A61K31/535 ,  A61K31/50 ,  A61K31/519

CPC classification number: C07D487/04 ,  C07D519/00

Abstract: The present invention is directed to novel compounds of formula (I) wherein the variables are defined as herein. The compounds of formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.